Mikkel Wandahl Pederson, CEO and chief scientific officer at Commit Biologics, discussed the company’s mission to harness the powerful complement system for the treatment of serious diseases.
Smart linkhttps://pc.st/e/2u64bwxbKR2
Official sitehttps://www.citeline.com/
Auto-openhttps://pc.st/e/2u64bwxbKR2?a
Add podcast to the siteEmbed Podcast





